Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov:143:528-533.
doi: 10.1016/j.jpsychires.2020.11.029. Epub 2020 Nov 17.

Impact of the coronavirus 2019 (COVID-19) pandemic on anxiety diagnosis in general practices in Germany

Louis Jacob  1 , Lee Smith  2 , Ai Koyanagi  3 , Hans Oh  4 , Christian Tanislav  5 , Jae Il Shin  6 , Marcel Konrad  7 , Karel Kostev  8
Affiliations

Impact of the coronavirus 2019 (COVID-19) pandemic on anxiety diagnosis in general practices in Germany

Louis Jacob et al. J Psychiatr Res. 2021 Nov.

Abstract

Little is known about the effects of the coronavirus disease-2019 (COVID-19) pandemic on the diagnosis of anxiety disorder. Therefore, the goal of this study was to compare the number of adults with a diagnosis of anxiety disorder and the number of adults newly diagnosed with anxiety disorder in Germany between January-June 2019 and January-June 2020, and to identify potential differences in terms of sociodemographic characteristics, prescriptions and comorbidities between these patients. The study included patients with at least one consultation in one of 1140 general practices in Germany in January-June 2019 and January-June 2020. Sociodemographic characteristics included age and sex, while there were three families of drugs and nine common comorbidities available for the analysis. An increase in the number of patients with anxiety disorder was observed in 2020 compared with 2019 (January: +4%, p = 0.643; February: +4%, p = 0.825; March: +34%, p < 0.001; April: +8%, p = 0.542; May: +2%, p = 0.382; June: +19%, p = 0.043; and March-June: + 19%, p < 0.001). There was also an increase in the number of patients newly diagnosed with anxiety disorder between March-June 2020 and March-June 2019 (11,502 versus 9506; +21%, p-value<0.001). Antidepressants, anxiolytics and herbal sedatives were less frequently prescribed in patients newly diagnosed with anxiety disorder in 2020 than in 2019 (30.4% versus 35.6%, p-value<0.001). Finally, COPD (9.4% versus 7.9%, p-value<0.001) and asthma (11.3% versus 9.7%, p-value<0.001) were more frequent in 2020 than in 2019. Taken these findings together, public health measures are urgently needed to mitigate the negative impact of the COVID-19 pandemic on anxiety disorder.

Keywords: Anxiety disorder; COVID-19; Coronavirus disease 2019; General practices; Germany; Pandemic.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Fig. 1
Fig. 1
Number of patients with anxiety disorder in German general practices in January–June 2019 and 2020.
Fig. 2
Fig. 2
Number of patients newly diagnosed with anxiety disorder in German general practices in January–June 2019 and 2020.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Bandelow B., Michaelis S., Wedekind D. Treatment of anxiety disorders. Dialogues Clin. Neurosci. 2017;19:93–107. - PMC - PubMed
    1. Bareket-Bojmel L., Shahar G., Margalit M. COVID-19-Related economic anxiety is as high as health anxiety: findings from the USA, the UK, and Israel. Int. J. Cognit. Ther. 2020;1–9 doi: 10.1007/s41811-020-00078-3. - DOI - PMC - PubMed
    1. Bäuerle A., Teufel M., Musche V., Weismüller B., Kohler H., Hetkamp M., Dörrie N., Schweda A., Skoda E.-M. Increased generalized anxiety, depression and distress during the COVID-19 pandemic: a cross-sectional study in Germany. J. Public Health. 2020 doi: 10.1093/pubmed/fdaa106. - DOI - PMC - PubMed
    1. Bendau A., Petzold M.B., Pyrkosch L., Mascarell Maricic L., Betzler F., Rogoll J., Große J., Ströhle A., Plag J. Associations between COVID-19 related media consumption and symptoms of anxiety, depression and COVID-19 related fear in the general population in Germany. Eur. Arch. Psychiatr. Clin. Neurosci. 2020:1–9. doi: 10.1007/s00406-020-01171-6. - DOI - PMC - PubMed
    1. Bijl R.V., de Graaf R., Hiripi E., Kessler R.C., Kohn R., Offord D.R., Ustun T.B., Vicente B., Vollebergh W.A.M., Walters E.E., Wittchen H.-U. The prevalence of treated and untreated mental disorders in five countries. Health Aff. 2003;22:122–133. doi: 10.1377/hlthaff.22.3.122. - DOI - PubMed